Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB
about
Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity.Caffeic acid phenethyl ester triggers apoptosis through induction of loss of mitochondrial membrane potential in CCRF-CEM cells.LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouseAbrogation of lectin-like oxidized LDL receptor-1 attenuates acute myocardial ischemia-induced renal dysfunction by modulating systemic and local inflammation.Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer.LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.Comparative antihypertensive efficacy of olmesartan: comparison with other angiotensin II receptor antagonists.Serum sLOX-1 Levels Are Correlated with the Presence and Severity of Obstructive Sleep ApneaOlmesartan attenuates the impairment of endothelial cells induced by oxidized low density lipoprotein through downregulating expression of LOX-1The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndromeDual role of oxidized LDL on the NF-kappaB signaling pathway.Thiazolidinediones and cardiovascular disease.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Position of fixed-dose combinations containing an AT(1)-receptor blocker and a thiazide diuretic.Interaction of oxidized low-density lipoprotein and the renin-angiotensin system in coronary artery disease.C-type lectin-like receptors on myeloid cells.Nigella sativa and Its Protective Role in Oxidative Stress and HypertensionEndoplasmic reticulum stress increases AT1R mRNA expression via TIA-1-dependent mechanism.Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?Activation of renin-angiotensin system is involved in dyslipidemia-mediated renal injuries in apolipoprotein E knockout mice and HK-2 cellsNon-antiarrhythmic medications for atrial fibrillation: from bench to clinical practice.Interaction of RAS activation and lipid disorders accelerates the progression of glomerulosclerosisVitamins and cardiovascular disease.Does reversal of oxidative stress and inflammation provide vascular protection?Protein Inhibitor of Activated STAT3 Suppresses Oxidized LDL-induced Cell Responses during Atherosclerosis in Apolipoprotein E-deficient Mice.Angiotensin II receptor blockers in the prevention of atrial fibrillation.Endothelial progenitor cell senescence--is there a role for estrogen?LOX-1: a critical player in the genesis and progression of myocardial ischemia.LOX-1 and angiotensin receptors, and their interplay.Do atherosclerosis and obesity-associated susceptibility to cancer share causative link to oxLDL and LOX-1?Novel concepts in the genesis of hypertension: role of LOX-1.Oxidized LDL, LOX-1 and atherosclerosis.Lectin-like oxidized low-density lipoprotein receptor 1 pathways.LOX-1 and ROS, inseparable factors in the process of endothelial damage.Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease.Ox-LDL Upregulates IL-6 Expression by Enhancing NF-κB in an IGF2-Dependent Manner in THP-1 Macrophages.Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.Genomics of cardiac remodeling in angiotensin II-treated wild-type and LOX-1-deficient mice.Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase.Caffeic acid phenethyl ester preferentially enhanced radiosensitizing and increased oxidative stress in medulloblastoma cell line.
P2860
Q33413089-B0B5ABB0-9633-4DC9-AE5C-4A6634032C9DQ33539833-81712F3F-7627-449D-A7EB-391772758188Q33709392-4D94E44D-7389-42AC-8F77-E32F04498124Q33710962-8B7C3595-BFE6-4C53-86AD-5331EBDED1A6Q33921431-AB120399-0400-401A-BFEE-E14621E2E760Q34079451-7403EADE-5629-4768-B6D6-63E9CA671CCBQ34660065-499BC105-B91F-4A8A-AA23-7331EF6BE6E7Q35608593-E0F504C1-72A2-4903-9DA8-5EF044CC49F7Q35795742-2E8ED377-43A3-4B6C-8591-230F3F2E2D49Q35850133-80251A26-01B9-454B-9008-F765DE20F35BQ35877997-3E3EE2C6-276D-4158-9147-999EF80F26DAQ36052956-A0F7DE3E-C952-496F-8EE2-991D32BBDA16Q36241932-107EA9F5-B7D5-4503-BA10-AFF155CB700EQ36364949-93A52B90-BD34-4A1C-9E6F-D1F5C89C50BEQ36467559-A2960761-8FC4-4C3C-90A4-08B2198466F5Q36497532-C4FA7EF8-A6E2-4CEE-86C1-9438C93BEBF7Q36711637-2B7CD114-E961-435E-8C83-290E4EB6E80AQ36817896-26A0647D-8385-455E-B4F1-20ACCB7A5BABQ36872076-826D5028-9B4B-484D-9ADD-C481D47DF574Q36996652-679CBA4D-1D3E-4871-9AA1-248883D44819Q37101383-72B9F3DD-C208-462E-B097-D3A6C1DF9B1FQ37246055-4558594B-FB45-4C6A-AEEE-7CC1CD1CF065Q37282850-5B3E254E-E201-4A83-BCA5-9EC36CC12A6EQ37355471-1EB95CA1-5A69-46AD-8CCE-4CADB59D568CQ37414017-13CB1148-0848-447E-BBA3-29EA20182315Q37494662-0C4331A3-54E1-4AFD-9F08-9439685EE906Q37645668-FB1474F7-30A3-4DD4-ACAE-8150B842F13FQ37918860-FB5918B2-D77B-402B-A53F-CD8B2288936FQ37921158-4352C9B9-A627-4B61-88D6-A003696CC65EQ37924631-914BE7C8-61A5-436E-9921-1401FBADD9FCQ37931043-347FCDFD-F438-47FB-90CD-BE4D73F6F661Q37938848-520CAFB5-CEE3-4D01-B9EE-5A2D9AB26BC7Q38099693-608086CA-3604-4E10-B234-A08799DD1C77Q38216728-3C422365-902B-4054-819E-6FC903CF6BF7Q38782387-81C9101E-28D6-4023-BB4B-3DA4F13C3D26Q38865214-A2DAFDBC-C159-4CAA-BF20-2530533007F3Q39203830-896C8A01-53AF-4850-9F2B-E04FED820CC6Q39724040-7DDA3418-332F-40F5-93C8-3BE1A7E8F731Q39879276-6A9C2A48-B04E-417C-A251-2A966696A6CFQ39983672-45B4B3D6-A19F-43DA-B4F7-FA5C6A8E5B19
P2860
Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB
description
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im Oktober 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 17 October 2000)
@en
vedecký článok (publikovaný 2000/10/17)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/10/17)
@nl
наукова стаття, опублікована в жовтні 2000
@uk
مقالة علمية (نشرت في 17-10-2000)
@ar
name
Oxidized LDL upregulates angio ...... transcription factor NF-kappaB
@ast
Oxidized LDL upregulates angio ...... transcription factor NF-kappaB
@en
Oxidized LDL upregulates angio ...... transcription factor NF-kappaB
@nl
type
label
Oxidized LDL upregulates angio ...... transcription factor NF-kappaB
@ast
Oxidized LDL upregulates angio ...... transcription factor NF-kappaB
@en
Oxidized LDL upregulates angio ...... transcription factor NF-kappaB
@nl
prefLabel
Oxidized LDL upregulates angio ...... transcription factor NF-kappaB
@ast
Oxidized LDL upregulates angio ...... transcription factor NF-kappaB
@en
Oxidized LDL upregulates angio ...... transcription factor NF-kappaB
@nl
P2093
P3181
P1433
P1476
Oxidized LDL upregulates angio ...... transcription factor NF-kappaB
@en
P2093
P304
P3181
P356
10.1161/01.CIR.102.16.1970
P407
P577
2000-10-17T00:00:00Z